Research News for April 1, 2020
advertisement
- The Association of Autoimmune Diseases with Type 1 Diabetes Mellitus in Children Depends Also by the Length of Partial Clinical Remission Phase (Honeymoon). (HTML)
- Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview. (HTML)
- Beta Cell Dedifferentiation Induced by IRE1α Deletion Prevents Type 1 Diabetes. (HTML)
- Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes. (HTML)
- A systematic review and meta-analysis of randomized controlled trials, juxtaposing the control of glycemia and blood pressure between large dose empagliflozin and placebo among type 1 diabetes patients. (HTML)
- Dyslipidemia in Type 1 Diabetes: A Masked Danger. (HTML)
- Evaluation of Electrocardiographic Ventricular Depolarization and Repolarization Variables in Type 1 Diabetes Mellitus. (HTML)
- Glycemic Control After Kidney Transplantation Using Sensor-augmented Insulin Pump Therapy in a Patient with Slowly Progressive Type 1 Diabetes Mellitus. (PDF)
- History of Insulin Treatment in Children and Adolescents with Diabetes in Japan.
- Global Inequality in Type 1 Diabetes: a Comparison of Switzerland and Low-and Middle-Income Countries.
- Update on Worldwide Trends in Occurrence of Childhood Type 1 Diabetes in 2020.
- The Discovery and Structure of Human Insulin.
- A forskolin-conjugated insulin analog targeting endogenous glucose-transporter for glucose-responsive insulin delivery. (HTML)